Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

$AMD, $ASND, $HOME, $KMI, $WH

Daily HeffX-LTN reviews Wall Street analysts research reports to find new investing and trading ideas for our readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of Wall Street’s Top analysts outlook for Key issues for Wednesday, as follows:

Advanced Micro Devices Inc. (NASDAQ: AMD) was started with a Hold rating at Benchmark. The 52-wk trading range is 9.04 – 17.34, and the consensus price target is posted at 14.87.

Ascendis Pharmaceutical A/S (NASDAQ:ASND) was started with a Buy rating and an 85 price objective at Stifel. That compares to the consensus target of 81.69. The Stifel team views company’s proprietary TransCon technology as game-changing in its potential to fix the pharmacokinetic and related clinical shortcomings of both currently approved blockbuster drugs as well as others in development.

At Home Group Inc. (NASDAQ:HOME) was raised to Overweight from Equal Weight at Morgan Stanley. The stock had traded in a range of 20.07 – 39.31 over the past year. The consensus price target is 41.56.

Kinder Morgan Inc. (NYSE:KMI)raised to Outperform from Market Perform at Bernstein. The 52-wk trading range is 14.69 – 21.25, and the consensus price target is 20.55.

Wyndham Hotels & Resorts Inc. (NYSE:WH) was added to the prestigious Conviction Buy List at Goldman Sachs. The 52-wk trading range is 57.29 to 66.95, and the consensus price target is set at 74.

Stay tuned…

  AMD, analysts, ASND, buy, hold, home, ideas, KMI, research, sage, street, trading, Wall, WH

The following two tabs change content below.

• Bio
• Latest Posts

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

Latest posts by Paul Ebeling (see all)

• Stay Warm, Cold Air Can Be Dangerous - February 23, 2019
• If Marijuana is Medicine So is Jack Daniels - February 23, 2019
• Trump Policy: Overhaul the Fed! - February 23, 2019